A Pilot Evaluation of Expedited Partner Treatment and Partner Human Immunodeficiency Virus Self-Testing Among Adolescent Girls and Young Women Diagnosed With Chlamydia trachomatis and Neisseria gonorrhoeae in Kisumu, Kenya

Victor Omollo, Elizabeth A Bukusi, Lara Kidoguchi, Felix Mogaka, Josephine B Odoyo, Connie Celum, Jennifer Morton, Rachel Johnson, Jared M Baeten, Victor Omollo, Elizabeth A Bukusi, Lara Kidoguchi, Felix Mogaka, Josephine B Odoyo, Connie Celum, Jennifer Morton, Rachel Johnson, Jared M Baeten

Abstract

Background: Expedited partner treatment (EPT) is effective for preventing sexually transmitted infection recurrence, but concerns about intimate partner violence and missed opportunities for human immunology virus (HIV) testing have limited its use in African settings.

Methods: We conducted a pilot prospective evaluation of EPT among adolescent girls and young women (AGYW) accessing HIV preexposure prophylaxis in an implementation project in Kisumu, Kenya. Those with etiologic diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae were treated and given the option of delivering sexually transmitted infection medication and HIV self-test kits to their current sexual partner(s). At enrollment, we assessed their reasons for declining. Three months after they delivered medication and kits to the partner(s), we assessed their reasons for failing to deliver medication and kits to their partner and reported partner's reactions.

Results: Between September 2018 and March 2020, 63 AGYW were enrolled. The majority (59/63 [94%]) accepted EPT, and 50 (79%) of 63 partner HIV self-testing (HIVST). Three quarters (46/59) of those accepting EPT returned for the assessment visit with 41 (89%) of 46 successfully delivering medication to 54 partners, of whom 49 (91%) used it. Seventy percent (35/50) who took partner HIVST kits returned for the assessment, with 80% (28/35) reporting providing kits to 40 partners, of whom 38 (95%) used it. Reported barriers to EPT and partner HIVST uptake among women who declined included anticipated fear that their partner could become angry or violent and loss of relationship.

Conclusions: Both EPT and partner HIVST were acceptable despite noted barriers among Kenyan AGYW with etiologic diagnosis of Chlamydia trachomatis/Neisseria gonorrhoeae and their partners.

Trial registration: ClinicalTrials.gov NCT03490058.

Conflict of interest statement

Conflict of Interest: None declared.

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.

References

    1. World Health Organization . Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva: WHO/HIV, 2015. Available at: . Accessed March 10, 2021.
    1. The Joint United Nations Programme on HIV/AIDS . UNAIDS Data 2019. Geneva, 2019. Available at: . Accessed March 15, 2021.
    1. Mugwanya KK Pintye J Kinuthia J, et al. . Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya. PLoS Med 2019; 16:e1002885.
    1. Pintye J Kinuthia J Allen Roberts D, et al. . Integration of PrEP services into routine antenatal and postnatal care: Experiences from an implementation program in western Kenya. J Acquir Immune Defic Syndr 2018; 79:590–595.
    1. Centers for Disease Control and Prevention . Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: A clinical practice guideline. Atlanta, GA: CDC, 2018. Available at: . Accessed March 10, 2021.
    1. World Health Organization . Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: World Health Organization, 2015. Available at: . Accessed March 10, 2021.
    1. Ong JJ Baggaley RC Wi TE, et al. . Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: A systematic review and meta-analysis. JAMA Netw Open 2019; 2:e1917134.
    1. Stewart J Omollo V Odoyo J, et al. . High prevalence and incidence of bacterial STIs in young women at high risk of HIV prior to PrEP scale-up in Kenya. Presented at: The STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI) [P424]; 2019; Vancouver. CANA.
    1. Celum CL Delany-Moretlwe S Hosek S, et al. . Risk behavior, perception, and reasons for PrEP among young African women in HPTN 082. Boston, MA, USA. Presented at: The 2018 CROI Conference [P1049], 2018.
    1. World Health Organization . Sexually transmitted and other reproductive tract infections: a guide to essential practice. Geneva, Switzerland: WHO, 2005. Available at: . Accessed March 15, 2021.
    1. Kaida A Dietrich JJ Laher F, et al. . A high burden of asymptomatic genital tract infections undermines the syndromic management approach among adolescents and young adults in South Africa: Implications for HIV prevention efforts. BMC Infect Dis 2018; 18:499.
    1. White RG Moodley P McGrath N, et al. . Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa. Sex Transm Infect 2008; 84:528–534.
    1. Vallely LM Toliman P Ryan C, et al. . Performance of syndromic management for the detection and treatment of genital Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis among women attending antenatal, well woman and sexual health clinics in Papua New Guinea: A cross-section. BMJ Open 2017; 7:e018630.
    1. Moodley D Moodley P Sebitloane M, et al. . High prevalence and incidence of asymptomatic sexually transmitted infections during pregnancy and postdelivery in KwaZulu Natal, South Africa. Sex Transm Dis 2015; 42:43–47.
    1. Otieno FO Ndivo R Oswago S, et al. . Evaluation of syndromic management of sexually transmitted infections within the Kisumu incidence cohort study. Int J STD AIDS 2014; 25:851–859.
    1. Mlisana K Naicker N Werner L, et al. . Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012; 206:6–14.
    1. Alam N Chamot E Vermund SH, et al. . Partner notification for sexually transmitted infections in developing countries: A systematic review. BMC Public Health 2010; 10:19.
    1. Hosenfeld CB Workowski KA Berman S, et al. . Repeat infection with chlamydia and gonorrhea among females: A systematic review of the literature. Sex Transm Dis 2009; 36:478–489.
    1. Ferreira A Young T Mathews C, et al. . Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev 2013; 2013:CD002843.
    1. Golden MR Kerani RP Stenger M, et al. . Uptake and population-level impact of expedited partner therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: The Washington state community-level randomized trial of EPT. PLoS Med 2015; 12:e1001777.
    1. Kerani RP, Fleming M, Golden MR. Acceptability and intention to seek medical care after hypothetical receipt of patient-delivered partner therapy or electronic partner notification postcards among men who have sex with men: The partner's perspective. Sex Transm Dis 2013; 40:179–185.
    1. Unger JA Matemo D Pintye J, et al. . Patient-delivered partner treatment for chlamydia, gonorrhea, and trichomonas infection among pregnant and postpartum women in Kenya. Sex Transm Dis 2015; 42:637–642.
    1. Garrett NJ Osman F Maharaj B, et al. . Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries. PLoS One 2018; 13:e0196209.
    1. Mayanja Y Mukose AD Nakubulwa S, et al. . Acceptance of treatment of sexually transmitted infections for stable sexual partners by female sex workers in Kampala, Uganda. PLoS One 2016; 11:e0155383.
    1. Medley A Garcia-Moreno C McGill S, et al. . Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: Implications for prevention of mother-to-child transmission programmes. Bull World Health Organ 2004; 82:299–307.
    1. Golden MR Whittington WLH Handsfield HH, et al. . Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005; 352:676–685.
    1. Masters SH Agot K Obonyo B, et al. . Promoting partner testing and couples testing through secondary distribution of HIV self-tests: A randomized clinical trial. PLoS Med 2016; 13:e1002166.
    1. MacDonald MR. Expedited partner therapy-an opportunity in military medicine. Mil Med 2010; 175:ix–xi.
    1. Pai NP Vadnais C Denkinger C, et al. . Point-of-care testing for infectious diseases: Diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 2012; 9:e1001306.
    1. Mati C Ngugi C Wafula R, et al. . Syphilis testing at ANC in Kenya: Dual testing as a game changer towards eMTCT. Presented at: The STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI) [P289]; 2019; Vancouver. CANA.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera